×
ADVERTISEMENT

Imbruvica, Janssen

Jeff Sharman, MD, on Improving Response Rates in High-Risk CLL Patients

At the 2017 annual meeting of ASCO, Dr. Jeff Sharman, presented the findings of his study which suggests that ...

JUNE 6, 2017

Load more